Literature DB >> 17689046

Co-infection of the cotton rat (Sigmodon hispidus) with Staphylococcus aureus and influenza A virus results in synergistic disease.

LoRanee E Braun1, Deena E Sutter, Maryna C Eichelberger, Lioubov Pletneva, John F Kokai-Kun, Jorge C G Blanco, Gregory A Prince, Martin G Ottolini.   

Abstract

Bacterial super-infection of influenza patients is the primary cause of excess mortality during influenza pandemics, with Staphylococcus aureus (S. aureus) having the highest fatality rate. The cotton rat (Sigmodon hispidus) is an excellent model for both influenza and S. aureus pathogenesis, and therefore a potential tool to model co-infection. We compared physiologic and pathologic changes in cotton rats infected with both S. aureus and influenza A/Wuhan/359/95 (H3N2), with animals infected with each pathogen alone. Co-infected cotton rats demonstrated significantly higher mortality, lower temperatures on 2 and 3 days post-inoculation (p.i.), higher levels of bacteremia and pulmonary bacterial load 4 days p.i., and worse pathology 7 days p.i. Early indicators of exacerbated disease coincided with higher pulmonary mRNA levels for IL-1beta, IL-6, IL-10 and IFNy, supporting the idea that these may contribute to disease severity. Our results demonstrate that the cotton rat is a good model of influenza and S. aureus co-infection, with increased mortality and hypothermia as well as prolonged bacterial duration indicative of synergistic disease that may be the result of increased induction of both pro- and anti-inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17689046     DOI: 10.1016/j.micpath.2007.03.005

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  9 in total

1.  Susceptibility of Sigmodon hispidus.

Authors:  Krishnan Kolappaswamy
Journal:  Lab Anim (NY)       Date:  2015-06       Impact factor: 12.625

2.  Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity.

Authors:  Brian M Peters; Mairi C Noverr
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

Review 3.  Animal models of polymicrobial pneumonia.

Authors:  Sami Hraiech; Laurent Papazian; Jean-Marc Rolain; Fabienne Bregeon
Journal:  Drug Des Devel Ther       Date:  2015-06-26       Impact factor: 4.162

Review 4.  Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: A key role for mathematical modelling.

Authors:  Lulla Opatowski; Marc Baguelin; Rosalind M Eggo
Journal:  PLoS Pathog       Date:  2018-02-15       Impact factor: 6.823

5.  Case report of a child with influenza and fatal community-associated methicillin-resistant Staphylococcus aureus sepsis.

Authors:  Bruno Cruz Boettger; Thais Freitas Teles Rezende; Nathalia Bibiana Teixeira; Antonio Carlos Campos Pignatari; Carlos Roberto Veiga Kiffer
Journal:  Rev Soc Bras Med Trop       Date:  2020-06-22       Impact factor: 1.581

6.  Effect of aging on immunogenicity and efficacy of inactivated influenza vaccines in cotton rats Sigmodon hispidus.

Authors:  Marina S Boukhvalova; Emma Mortensen; Aissatou Mbaye; Jamall McKay; Jorge C G Blanco
Journal:  Hum Vaccin Immunother       Date:  2020-07-02       Impact factor: 3.452

Review 7.  Animal models for the study of influenza pathogenesis and therapy.

Authors:  Dale L Barnard
Journal:  Antiviral Res       Date:  2009-01-25       Impact factor: 5.970

8.  A Time Course for Susceptibility to Staphylococcus aureus Respiratory Infection during Influenza in a Swine Model.

Authors:  Elizabeth A Smith; Sandeep R P Kumar; Jagadeeswaran Deventhiran; Thomas E Cecere; Tanya Leroith; Mike McGilliard; Subbiah Elankumaran; Isis Kanevsky Mullarky
Journal:  Influenza Res Treat       Date:  2012-01-11

Review 9.  Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.

Authors:  Sébastien Boutin; Dagmar Hildebrand; Steeve Boulant; Michael Kreuter; Jule Rüter; Srinivas Reddy Pallerla; Thirumalaisamy P Velavan; Dennis Nurjadi
Journal:  Cell Mol Life Sci       Date:  2021-07-05       Impact factor: 9.261

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.